Global Specialty Enzymes Industry

• Publication date: October 2010

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following product segments - Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates ...

This report analyzes the worldwide markets for Specialty Enzymes in US$ Million by the following product segments - Specialty Medical Enzymes, Polymerases, Nucleases, and Other Specialty Enzymes. The specific end-use segments discussed are Pharmaceuticals & Diagnostics, and Research/Biotechnology. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets.The report profiles 44 companies including many key and niche players such as Advanced Enzymes Technologies Limited, Amano Enzyme Inc., Aureozyme Inc., Biocon Ltd., Biozyme Laboratories Limited, Danisco A/S, Genencor International, Inc., Kinetic Biosystems, Inc., Maxygen Inc, Codexis Inc., Novozymes A/S, Seravac Biotech (Pty) Ltd, Specialty Enzymes & Biochemicals Co., and Verenium Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Biotechnology Industry in Europe

SPECIALTY ENZYMES MCP-2056
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability And Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions And Scope Of Study 3
Specialty Medical Enzymes 4
Polymerases 4
Nucleases 4
Other Specialty Enzymes 4
Pharmaceuticals/Diagnostic 4
Research/Biotechnology 4

2. GLOBAL MARKET OVERVIEW 5
Current and Future Analysis 5
Recession Derails the Market Momentum 6
Competitive Scenario 6
Table 1: Leading Players in the Global Enzyme Market (2009):
Percentage Breakdown of Value Sales for Novozymes, Danisco,
Genzyme, Roche, Allergan, DSM and Others (includes
corresponding Graph/Chart) 6

3. ENZYMES - A REVIEW 7
Definition 7
Introduction 7
Advantages of Enzymes Compared to Chemical Catalysts 8
A Brief History 8

4. SPECIALTY ENZYMES: AN OVERVIEW 9
Analysis of Product Segments 9
Specialty Medical Enzymes 9
Polymerases 10
Nucleases 10
Other Specialty Enzymes 10

5. ANALYSIS OF THE END-USE MARKETS 11
Pharmaceuticals & Diagnostics 11
Research/Biotechnology 11
Other End Use Markets 11

6. TECHNOLOGY TRENDS 12
Protein Engineering Technology 12
Specialty Enzymes in Industrial Uses 12
Enzyme Technology in Pig Industry 13

7. PRODUCT INTRODUCTIONS/INNOVATIONS 14
Verenium Launches Xylathin 14
Novagen Introduces Novagen® KOD XtremeTM Hot Start DNA
Polymerase Kit 14
Verenium Launches New Veretase High-Performance Enzyme 14

8. PRODUCT INNOVATIONS/LAUNCHES IN RECENT PAST -
A PERSPECTIVE BUILDER 16
MARDI Develops Taq DNA Polymerase 16
Stratagene Corporation Commercializes DNA Polymerases 16
Takara Bio Launches PrimeSTAR HS DNA Polymerase 16

9. RECENT INDUSTRY ACTIVITY 17
Thermo Fisher Scientific Acquires Finnzymes 17
Verenium and Add Food Service Enter into an Agreement 17
Verenium and Syngenta End Collaborative Research Program 17
Verenium Collaborates with Alfa Laval for Purifine PLC Enzyme 18
Verenium and Bunge Enter into an Agreement for Enzyme Process
Development 18
Inverness Medical Innovations Acquires BBI Holdings Plc 19
Helix Biopharma Enters into a Contract with KBI Biopharma 19
Verenium Enters into Agreement with Bunge Oils 19

10. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 20
BBI Holdings Acquires Theratase Plc 20
Danisco to Acquire Stake in South African Firm 20
Affymetrix to Buy USB Corporation 20
Diversa Merges with Celunol to Form Verenium Corporation 20
Diversa Collaborates with BASF 20
Codexis Expands Collaboration with Royal Dutch Shell to
Develop Super Enzymes 21
Diversa Enters into a Deal with Syngenta to Develop Enzymes 21
Genencor Begins Operation at New China Site and Introduces a
New Detergent Enzyme 21
Verenium Receives $4.6 million For Enzyme Development 21
Biocon Divests its Enzymes Business to Novozymes 21
Solexa Signs Agreement with New England Biolabs 22
Danisco Takes Over Genencor 22
IBEX Technologies Inks Agreement with Cape Cod and Prozyme 22

11. FOCUS ON SELECT GLOBAL PLAYERS 23
Advanced Enzymes Technologies Limited (India) 23
Amano Enzyme, Inc. (Japan) 23
Aureozyme, Inc. (US) 23
Biocon Ltd. (India) 24
Biozyme Laboratories Limited (UK) 24
Danisco A/S (Denmark) 25
Genencor International, Inc. (US) 25
Kinetic Biosystems, Inc. (US) 26
Maxygen, Inc. (US) 26
Codexis Inc. (US) 26
Novozymes A/S (Denmark) 26
Seravac Biotech (Pty) Ltd. (South Africa) 27
Specialty Enzymes & Biotechnologies Co. (US) 27
Verenium Corporation (US) 27

12. GLOBAL MARKET PERSPECTIVE 28
Table 2: World Recent Past, Current & Future Analysis for
Specialty Enzymes by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 28

Table 3: World Historic Review for Specialty Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 29

Table 4: World 11-Year Perspective for Specialty Enzymes by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 30

Table 5: World Recent Past, Current & Future Analysis for
Specialty Medical Enzymes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East,
and Latin America Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 31

Table 6: World Historic Review for Specialty Medical Enzymes
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 32

Table 7: World 11-Year Perspective for Specialty Medical
Enzymes by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 33

Table 8: World Recent Past, Current & Future Analysis for
Polymerases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 34

Table 9: World Historic Review for Polymerases by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 35

Table 10: World 11-Year Perspective for Polymerases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 36

Table 11: World Recent Past, Current & Future Analysis for
Nucleases by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East, and Latin America
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 37

Table 12: World Historic Review for Nucleases by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 38

Table 13: World 11-Year Perspective for Nucleases by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 39

Table 14: World Recent Past, Current & Future Analysis for
Other Specialty Enzymes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East,
and Latin America Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 40

Table 15: World Historic Review for Other Specialty Enzymes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 41

Table 16: World 11-Year Perspective for Other Specialty
Enzymes by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 42

Table 17: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Pharmaceuticals & Diagnostics
by Geographic Region- US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 43

Table 18: World Historic Review for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region- US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East, and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 44

Table 19: World 11-Year Perspective for Specialty Enzymes
Consumption in Pharmaceuticals & Diagnostics by Geographic
Region - Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East,
and Latin America Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 45

Table 20: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Research/Biotechnology by
Geographic Region- US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 46

Table 21: World Historic Review for Specialty Enzymes
Consumption in Research/Biotechnology by Geographic Region-
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 47

Table 22: World 11-Year Perspective for Specialty Enzymes
Consumption in Research/Biotechnology by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and Latin
America Markets for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 48

Table 23: World Recent Past, Current & Future Analysis for
Specialty Enzymes Consumption in Other End-Use Segments by
Geographic Region- US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East, and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 49

Table 24: World Historic Review for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region-
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East, and Latin America Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 50

Table 25: World 11-Year Perspective for Specialty Enzymes
Consumption in Other End-Use Segments by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East, and Latin
America Markets for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 51

13. THE UNITED STATES 52
A.Market Analysis 52
Current and Future Analysis 52
Competitive Scenario 52
Table 26: Leading Players in the US Enzyme Market (2008):
Percentage Breakdown of Value Sales for Novozymes, Danisco,
Allergan, Genzyme, Genentech, and Others (includes
corresponding Graph/Chart) 52
Market Dynamics 53
Specialty Enzymes Market is Projected to Rise 53
Specialty Enzymes Form the Leading Enzymes Segment 53
Pharmaceuticals and Diagnostics Continue to be the Largest
Market 53
Specialty Medical Enzymes in a Myriad of Novel Applications 53
Market for Enzymes in Biotechnology 53
B.Market Analytics 54
Table 27: US Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 54

Table 28: US Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 55

Table 29: US 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 56

Table 30: US Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 57

Table 31: US Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 58

Table 32: US 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/Biotechnology and
Others Markets for 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 58

14. CANADA 59
Market Analysis 59
Table 33: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015(includes corresponding
Graph/Chart) 59

Table 34: Canadian Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 60

Table 35: Canadian 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 61

Table 36: Canadian Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research / Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 62

Table 37: Canadian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 63

Table 38: Canadian 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 63

15. JAPAN 64
Market Analysis 64
Table 39: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 64

Table 40: Japanese Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 65

Table 41: Japanese 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 66

Table 42: Japanese Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 67

Table 43: Japanese Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 68

Table 44: Japanese 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research / Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 68

16. EUROPE 69
Market Analysis 69
Table 45: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Geographic Region - France,
Germany, Italy, UK, Spain, Russia, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 70

Table 46: European Historic Review for Specialty Enzymes by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 71

Table 47: European 11-Year Perspective for Specialty Enzymes
by Geographic Region - Percentage Breakdown of Dollar Sales
for France, Germany, Italy, UK, Spain, Russia, and Rest of
Europe Markets for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 72

Table 48: European Recent Past, Current & Future Analysis
for Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 73

Table 49: European Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 74

Table 50: European 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 75

Table 51: European Recent Past, Current & Future Analysis
for Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 76

Table 52: European Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 77

Table 53: European 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 78

16a. FRANCE 79
Market Analysis 79
Table 54: French Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 79

Table 55: French Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 80

Table 56: French 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 81

Table 57: French Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/ Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 82

Table 58: French Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 83

Table 59: French 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 83

16b. GERMANY 84
Market Analysis 84
Table 60: German Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 84

Table 61: German Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 85

Table 62: German 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 86

Table 63: German Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 87

Table 64: German Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 88

Table 65: German 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 88

16c. ITALY 89
Market Analysis 89
Table 66: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 89

Table 67: Italian Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 90

Table 68: Italian 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 91

Table 69: Italian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 92

Table 70: Italian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 93

Table 71: Italian 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 93

16d. THE UNITED KINGDOM 94
Market Analysis 94
Table 72: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 94

Table 73: UK Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 95

Table 74: UK 11-Year Perspective for Specialty Enzymes by
Product Segment - Percentage Breakdown of Dollar Sales for
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 96

Table 75: UK Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 97

Table 76: UK Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2006 (includes corresponding Graph/Chart) 98

Table 77: UK 11-Year Perspective for Specialty Enzymes by
End-Use Segment - Percentage Breakdown of Dollar Sales for
Pharmaceuticals & Diagnostics, Research/ Biotechnology and
Others Markets for2005, 2010 & 2015 (includes corresponding
Graph/Chart) 98

16e. SPAIN 99
Market Analysis 99
Table 78: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 99

Table 79: Spanish Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 100

Table 80: Spanish 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015(includes
corresponding Graph/Chart) 101

Table 81: Spanish Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015(includes corresponding
Graph/Chart) 102

Table 82: Spanish Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 103

Table 83: Spanish 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research/ Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 103

16f. RUSSIA 104
Market Analysis 104
Table 84: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by Product Segment - Specialty Medical
Enzymes, Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 104

Table 85: Russian Historic Review for Specialty Enzymes by
Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 105

Table 86: Russian 11-Year Perspective for Specialty Enzymes
by Product Segment - Percentage Breakdown of Dollar Sales
for Specialty Medical Enzymes, Polymerases, Nucleases and
Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 106

Table 87: Russian Recent Past, Current & Future Analysis for
Specialty Enzymes by End-Use Segment - Pharmaceuticals &
Diagnostics, Research/Biotechnology and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 107

Table 88: Russian Historic Review for Specialty Enzymes by
End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 108

Table 89: Russian 11-Year Perspective for Specialty Enzymes
by End-Use Segment - Percentage Breakdown of Dollar Sales
for Pharmaceuticals & Diagnostics, Research / Biotechnology
and Others Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 108

16g. REST OF EUROPE 109
Market Analysis 109
Table 90: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 109

Table 91: Rest of Europe Historic Review for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 110

Table 92: Rest of Europe 11-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 111

Table 93: Rest of Europe Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research / Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 112

Table 94: Rest of Europe Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research / Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 113

Table 95: Rest of Europe 11-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 114

17. ASIA-PACIFIC 115
A.Market Analysis 115
Current and Future Analysis 115
Enzyme Market in China 115
Enzyme Demand by End-Use 115
Table 96: Chinese Enzyme Market (2009): Percentage
Breakdown of Dollar Demand by End-Use Market - Industrial
(Food & Beverage, Cleaning Products, Animal Feed, Ethanol
Production, and Other Industrial) and Specialty (includes
corresponding Graph/Chart) 116
Enzyme Demand by Enzyme Type 116
Table 97: Chinese Enzyme Market (2009): Percentage
Breakdown of Dollar Demand by Enzyme Type - Carbohydrases
(Amylases and Other Carbohydrases), Proteases, Lipases,
Polymerases & Nucleases, and Other Enzymes (includes
corresponding Graph/Chart) 116
B.Market Analytics 117
Table 98: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 117

Table 99: Asia-Pacific Historic Review for Specialty Enzymes
by Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 118

Table 100: Asia-Pacific 11-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 119

Table 101: Asia-Pacific Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research / Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 120

Table 102: Asia-Pacific Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research / Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 121

Table 103: Asia-Pacific 11-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 122

18. THE MIDDLE EAST 123
Market Analysis 123
Table 104: Middle East Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 123

Table 105: Middle East Historic Review for Specialty Enzymes
by Product Segment - Specialty Medical Enzymes, Polymerases,
Nucleases and Other Enzymes Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 124

Table 106: Middle East 11-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 125

Table 107: Middle East Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 126

Table 108: Middle East Historic Review for Specialty Enzymes
by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 127

Table 109: Middle East 11-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 128

19. LATIN AMERICA 129
Market Analysis 129
Table 110: Latin American Recent Past, Current & Future
Analysis for Specialty Enzymes by Product Segment -
Specialty Medical Enzymes, Polymerases, Nucleases and Other
Enzymes Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 129

Table 111: Latin American Historic Review for Specialty
Enzymes by Product Segment - Specialty Medical Enzymes,
Polymerases, Nucleases and Other Enzymes Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 130

Table 112: Latin American 11-Year Perspective for Specialty
Enzymes by Product Segment - Percentage Breakdown of Dollar
Sales for Specialty Medical Enzymes, Polymerases, Nucleases
and Other Enzymes Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 131

Table 113: Latin American Recent Past, Current & Future
Analysis for Specialty Enzymes by End-Use Segment -
Pharmaceuticals & Diagnostics, Research/ Biotechnology and
Others Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 132

Table 114: Latin American Historic Review for Specialty
Enzymes by End-Use Segment - Pharmaceuticals & Diagnostics,
Research/Biotechnology and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 133

Table 115: Latin American 11-Year Perspective for Specialty
Enzymes by End-Use Segment - Percentage Breakdown of Dollar
Sales for Pharmaceuticals & Diagnostics, Research/
Biotechnology and Others Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 134


COMPETITION

Total Companies Profiled: 44 (including Divisions/Subsidiaries - 46)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 25
Canada 3
Japan 2
Europe 11
Germany 1
The United Kingdom 2
Rest of Europe 8
Asia-Pacific (Excluding Japan) 4
Africa 1
------------------------------------------